PharVision Advisers’s SunCoke Energy SXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,762
Closed -$110K 792
2025
Q2
$110K Sell
12,762
-30,018
-70% -$260K 0.16% 248
2025
Q1
$394K Sell
42,780
-6,718
-14% -$64.5K 0.55% 35
2024
Q4
$530K Buy
+49,498
New +$530K 0.45% 36

Other funds holding SXC

PharVision Advisers's SXC Position: Q3 2025 in Review

PharVision Advisers sold out of SunCoke Energy (SXC) in Q3 2025, closing a stake of 12,762 shares — an estimated $110K sold.

PharVision Advisers first reported a position in SXC in Q4 2024 and held it in 3 quarters. The position peaked at $530K in Q4 2024. 228 funds tracked by Wall St. Rank hold SXC as of Q3 2025.

  • PharVision Advisers reported no remaining SunCoke Energy position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 12,762 SunCoke Energy shares in Q3 2025, an estimated $110K.
  • PharVision Advisers first reported a position in SunCoke Energy in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's SunCoke Energy position peaked at $530K in Q4 2024.
  • 228 funds tracked by Wall St. Rank held SunCoke Energy as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.